Last updated: Nov 20, 2026, 12:00 AM

Biomarin Pharmaceutical Inc Exchange (NASDAQ, USD)

BMRN

61.43
+2.92 (+4.99%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
12.80%
3 year return (CAGR)
-9.69%
5 year return (CAGR)
-5.51%
10 year return (CAGR)
-3.01%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
11.89B
Price/Sales
3.49
Ent value
16.47B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
162.96
PEG
-
Forward P/E
9.62
EPS growth
-50.02%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open58.50
Daily high61.70
Daily low58.27
Daily Volume3.01M
All-time high149.13
1y analyst estimate91.33
Beta0.23
EPS (TTM)0.38
Dividend per share0.00
Ex-div date-
Next earnings date25 Feb 2026

Ready to capitalize on Biomarin Pharmaceutical Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
BMRNS&P500
Current price drop from All-time high-58.81%-6.28%
Highest price drop-90.58%-56.47%
Date of highest drop27 Aug 20029 Mar 2009
Avg drop from high-45.74%-10.64%
Avg time to new high58 days12 days
Max time to new high2851 days1805 days